1153P Preclinical characterization of MC339: A novel radiotherapeutic agent for DLL3 expressing cancers
| Autor: | Savinainen, A., Wu, L., Bruton, T., Chonkar, A., Cupido, J., Dearling, J., Huang, C., Lee, K., Ma, Z., Mok, H., Nabi, K., Salih, A., Sutton, A., Tavera, L., Wan, M., Wang, Z., Xu, X., Xu, J., Zidell, A., Ricardo, A. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S755-S755 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|